George Kaiser Family Foundation Ptc Therapeutics, Inc. Transaction History

George Kaiser Family Foundation

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$18.07 - $29.37 $387,348 - $629,575	-21,436 Reduced 46.79%	24,380 $671,000
Q3 2023 Nov 13, 2023	SELL	$22.41 - $41.99 $173,811 - $325,674	-7,756 Reduced 14.48%	45,816 $1.03 Million
Q1 2023 May 10, 2023	SELL	$38.16 - $48.86 $3,701 - $4,739	-97 Reduced 0.18%	53,572 $2.6 Million
Q1 2022 May 11, 2022	SELL	$33.33 - $44.6 $612,372 - $819,435	-18,373 Reduced 25.5%	53,669 $5.78 Million
Q4 2021 Feb 08, 2022	SELL	$35.36 - $41.86 $2,227 - $2,637	-63 Reduced 0.09%	72,042 $8.73 Million
Q1 2021 May 14, 2021	SELL	$46.8 - $68.92 $838,000 - $1.23 Million	-17,906 Reduced 19.89%	72,105 $9.93 Million
Q4 2020 Feb 11, 2021	BUY	$47.96 - $67.64 $4.32 Million - $6.09 Million	90,011 New	90,011 $10.8 Million

219

78.2M

111K

30.6K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of George Kaiser Family Foundation, based on Form 13F filings with the SEC.

Stay updated on George Kaiser Family Foundation with notifications on news.